EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-ND 4.0

Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage

Queralt Asla, Maite Garrido, Eulàlia Urgell, Sílvia Terzan, Alicia Santos, Nimmy Varghese, Cihan Atila iD, Betina Biagetti, Franziska Plessow, Mirjam Christ-Crain iD, Anne Eckert, Susan M Webb und 2 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf201 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Queralt Asla und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, ENDO-ERN, 08025 Barcelona, Spain. Hauptthemen laut MEDLINE: Hypopituitarism, Hypothalamic Diseases, Hypothalamus, Melatonin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Fundació de Gestió Sanitària de l'Hospital de la Santa Creu, III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Increasing evidence supports the presence of oxytocin deficiency (OXT-D) in hypopituitarism and hypothalamic damage (HHD). Identifying an applicable and reliable test to diagnose OXT-D is an unmet need. Melatonin (MEL) might be a candidate for such a test as it regulates OXT release in animals.

Objective

This work aimed to examine the effects of melatonin on OXT release in HHD compared to healthy controls (HCs) and to describe the psychopathology, sexual function, and quality of life (QoL) and their associations with OXT.

Methods

This proof-of-concept study (NCT05319301) included 20 participants with HHD (11 women) and 20 HCs (11 women). Blood samples were collected over 120 minutes to assess plasma OXT. A linear mixed-effects regression model was used to evaluate the change in OXT in response to MEL in HHD compared to HCs.

Results

MEL significantly increased OXT at T90 vs T0 in HCs compared to the HHD group (difference 14.57 pg/mL 26% increase; 95% CI, 1.90-27.23; P = .02). The HHD group had more depression symptoms, alexithymia, impaired sexual function, and worse QoL compared to HCs. The mean percentage change in OXT from T0 to T90 was negatively associated with depressive and alexithymia symptoms in the HHD group and anxiety in both groups.

Conclusion

The reduced OXT response after MEL in HHD supports the existence of an impaired OXT response at least in a subset of patients with HHD. The associations between OXT changes and psychopathology suggest its role in mood and QoL. These findings support further investigation into MEL’s role as a diagnostic tool to address OXT-D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypopituitarismHypothalamic DiseasesHypothalamusMelatoninOxytocinAdultFemaleHumansMaleMiddle AgedYoung AdultCase-Control StudiesProof of Concept StudyQuality of Life

Stichwörter der Autor:innen

arginine-vasopressin deficiencyhypopituitarismmelatoninoxytocinpineal glandstimulation test

Substanzen

MelatoninOxytocin

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, ENDO-ERN, 08025 Barcelona, Spain.
  • Institut de Recerca Sant Pau (IR-SANT PAU), 08041 Barcelona, Spain.
  • Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic/Manresa, Catalonia, Spain.
  • Centre d'Investigació del Medicament (CIM), IR-SANT PAU, 08041 Barcelona, Spain.
  • Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unit 747), Instituto de Salud Carlos III, 28222 Majadahonda, Spain.

ORCID-Profile: Cihan Atila, Mirjam Christ-Crain, Anna Aulinas

Förderung

  • NIDDK NIH HHS
  • Fundació de Gestió Sanitària de l'Hospital de la Santa Creu
  • III
  • Instituto de Salud Carlos
  • European Regional Development Fund
  • European Social Fund
  • Fundació de Gestió Sanitària de l’Hospital de la Santa Creu

Zitieren

APA

Asla, Q., Garrido, M., Urgell, E., Terzan, S., Santos, A., Varghese, N., Atila, C., Biagetti, B., Plessow, F., Christ-Crain, M., Eckert, A., Webb, S. M., Lawson, E. A., & Aulinas, A. (2025). Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf201

Vancouver

Asla Q, Garrido M, Urgell E, Terzan S, Santos A, Varghese N, et al. Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf201

BibTeX
@article{Asla2025,
  author = {Asla, Queralt and Garrido, Maite and Urgell, Eulàlia and Terzan, Sílvia and Santos, Alicia and Varghese, Nimmy and Atila, Cihan and Biagetti, Betina and Plessow, Franziska and Christ-Crain, Mirjam and Eckert, Anne and Webb, Susan M and Lawson, Elizabeth A and Aulinas, Anna},
  title = {Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf201}
}
Kostenlos starten →